While mucosal vaccines have the potential to solve a number of high impact diseases such as HIV and TB, the development of mucosal vaccines has so far been a low priority on the global health agenda. The European Commission through the MUVAPRED program has been able to focus diverse academic and industrial partners on the development of mucosal vaccines and to move the field considerably, proving that mucosal vaccines against poverty-related diseases can work in humans.
Medaglini, D., Olesen, O.f., Rappuoli, R. (2009). The European effort towards the development of mucosal vaccines for poverty-related diseases. VACCINE, 27, 2641-2648 [10.1016/j.vaccine.2009.02.070].
The European effort towards the development of mucosal vaccines for poverty-related diseases.
MEDAGLINI, DONATA;
2009-01-01
Abstract
While mucosal vaccines have the potential to solve a number of high impact diseases such as HIV and TB, the development of mucosal vaccines has so far been a low priority on the global health agenda. The European Commission through the MUVAPRED program has been able to focus diverse academic and industrial partners on the development of mucosal vaccines and to move the field considerably, proving that mucosal vaccines against poverty-related diseases can work in humans.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Vaccine27-2009.pdf
non disponibili
Tipologia:
Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
734.09 kB
Formato
Adobe PDF
|
734.09 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/11079
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo